Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | IGLV6-57 | P01721 | 1/20 | 0.33 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18757121 | 0.83 | HCAR3 (0.36) | ALDH1A1TDP1TAAR1HTTMAPT | |
| SCHEMBL11404693 | 0.83 | HIF1A (0.41) | ALDH1A1TDP1HTTSMN1; SMN2TP53 | |
| SCHEMBL10348155 | 0.80 | ALDH1A1 (0.42) | ALDH1A1TDP1TAAR1HTTMAPT | |
| SCHEMBL19007315 | 0.79 | HTT (0.39) | ALDH1A1TDP1TAAR1HTTSMN1; SMN2 | |
| SCHEMBL20201658 | 0.79 | AKR1B1 (0.46) | TAAR1HTTMAPTSMN1; SMN2CYP1A2 | |
| SCHEMBL28026747 | 0.79 | CYP3A4 (0.42) | MAPTTP53POLBTSHRCYP3A4 | |
| SCHEMBL15264049 | 0.79 | ALDH1A1 (0.46) | ALDH1A1TDP1MAPTSMN1; SMN2TP53 | |
| SCHEMBL19633546 | 0.79 | TDP1 (0.46) | ALDH1A1TDP1MAPTSMN1; SMN2TP53 | |
| SCHEMBL18228338 | 0.79 | PYCR1 (0.37) | ALDH1A1TAAR1HTTLMNATSHR | |
| SCHEMBL23469288 | 0.79 | ALDH1A1 (0.38) | ALDH1A1HTTMAPTSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9758688-B2 | Composition for forming conductive film | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-09-12 | — | — | US | disclosed |
| US-9704612-B2 | Composition of silver-conjugated compound composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-11 | — | — | US | disclosed |
| US-9536633-B2 | Metallic composite and composition thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-01-03 | — | — | US | disclosed |
| US-9412487-B2 | Silver-(conjugated compound) composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20150275015-A1 | COMPOSITION FOR FORMING CONDUCTIVE FILM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-01 | — | — | US | disclosed |
| US-8866134-B2 | Light-emitting device and photovoltaic cell, and method for manufacturing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-10-21 | — | — | US | disclosed |
| US-20130099224-A1 | LIGHT-EMITTING DEVICE AND PHOTOVOLTAIC CELL, AND METHOD FOR MANUFACTURING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-25 | — | — | US | disclosed |
| US-20120168693-A1 | SILVER-(CONJUGATED COMPOUND) COMPOSITE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120032121-A1 | METALLIC COMPOSITE AND COMPOSITION THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120032121-A1 | METALLIC COMPOSITE AND COMPOSITION THEREOF | CDH1, EPCAM, CD4 | ALDH1A1 932/4885TDP1 4138/4885TAAR1 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.